0001365916-22-000107.txt : 20220829
0001365916-22-000107.hdr.sgml : 20220829
20220829191033
ACCESSION NUMBER: 0001365916-22-000107
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220822
FILED AS OF DATE: 20220829
DATE AS OF CHANGE: 20220829
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kung Frank
CENTRAL INDEX KEY: 0001227255
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34885
FILM NUMBER: 221212498
MAIL ADDRESS:
STREET 1: C/O VIVO CAPITAL
STREET 2: 505
CITY: PALO ALTO
STATE: CA
ZIP: 94301
FORMER NAME:
FORMER CONFORMED NAME: KUNG FRANK
DATE OF NAME CHANGE: 20030414
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMYRIS, INC.
CENTRAL INDEX KEY: 0001365916
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 550856151
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-0761
MAIL ADDRESS:
STREET 1: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC
DATE OF NAME CHANGE: 20060613
4/A
1
wf-form4a_166181461369437.xml
FORM 4/A
X0306
4/A
2022-08-22
2022-08-24
0
0001365916
AMYRIS, INC.
AMRS
0001227255
Kung Frank
C/O AMYRIS, INC.
5885 HOLLIS STREET, SUITE 100
EMERYVILLE
CA
94608
1
0
0
0
Common Stock
2022-08-22
4
A
0
80000
0
A
87409
D
Common Stock
2022-08-23
4
J
0
7409
0
D
80000
D
Common Stock
2022-08-23
4
J
0
7409
0
A
16207
I
by Vivo Capital LLC
Common Stock
6796205
I
by Vivo Capital Fund VIII, L.P.
Common Stock
3187518
I
by Vivo Opportunity Fund, LP
Common Stock
938416
I
by Vivo Capital Surplus Fund VIII, L.P.
Common Stock
711258
I
by Vivo Capital Fund IX, LP
Pursuant to an agreement dated November 2, 2017 between the Reporting Person and Vivo Capital LLC, the Reporting Person agreed to remit the equity compensation received under Issuer's non-employee director compensation program to Vivo Capital if and when such equity compensation becomes vested and/or exercised.
The Reporting Person is a voting member of Vivo Capital LLC and may be deemed to share voting and dispositive power over these shares with five (5) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
The General Partner of the holder is Vivo Capital VIII, LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with four (4) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
The General Partner of the holder is Vivo Opportunity, LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with four (4) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
The General Partner of the holder is Vivo Capital IX LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with six (6) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
The Form 4 filed by the Reporting Person on August 24, 2022 inadvertently excluded the Reporting Person's transfer to indirect holdings as detailed in footnote 1 above.
/s/ Frank Kung by Bruna Lawant Attorney-in-Fact
2022-08-29